Discovery of protein’s role could improve cancer immunotherapies
Drug Discovery World
JUNE 19, 2024
TIMP-1 is produced by dendritic cells, which are responsible for initiating immune responses and boosting the immune system’s ability to recognise and destroy cancer cells. The protein enhances antitumour immunity through self-stimulation and by activating surrounding immune cells.
Let's personalize your content